BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29503629)

  • 1. A Score for Risk of Thrombolysis-Associated Hemorrhage Including Pretreatment with Statins.
    Erdur H; Polymeris A; Grittner U; Scheitz JF; Tütüncü S; Seiffge DJ; Audebert HJ; Nolte CH; Engelter ST; Rocco A
    Front Neurol; 2018; 9():74. PubMed ID: 29503629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupat P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2622-2629. PubMed ID: 28826584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
    Mazya M; Egido JA; Ford GA; Lees KR; Mikulik R; Toni D; Wahlgren N; Ahmed N;
    Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator.
    Muengtaweepongsa S; Prapa-Anantachai P; Dharmasaroja PA
    J Neurosci Rural Pract; 2017; 8(1):49-54. PubMed ID: 28149081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.
    Scheitz JF; Seiffge DJ; Tütüncü S; Gensicke H; Audebert HJ; Bonati LH; Fiebach JB; Tränka C; Lyrer PA; Endres M; Engelter ST; Nolte CH
    Stroke; 2014 Feb; 45(2):509-14. PubMed ID: 24368561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage.
    Tsivgoulis G; Frey JL; Flaster M; Sharma VK; Lao AY; Hoover SL; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2009 Nov; 40(11):3631-4. PubMed ID: 19762689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
    Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.
    Tanaka K; Matsumoto S; Furuta K; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
    Cappellari M; Turcato G; Forlivesi S; Zivelonghi C; Bovi P; Bonetti B; Toni D
    Stroke; 2018 Feb; 49(2):397-404. PubMed ID: 29311264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
    Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
    Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage.
    Liu M; Pan Y; Zhou L; Wang Y
    Neurol Res; 2019 May; 41(5):473-479. PubMed ID: 30822264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Sung SF; Chen SC; Lin HJ; Chen YW; Tseng MC; Chen CH
    Stroke; 2013 Jun; 44(6):1561-6. PubMed ID: 23632979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis.
    Mazya MV; Bovi P; Castillo J; Jatuzis D; Kobayashi A; Wahlgren N; Ahmed N
    Stroke; 2013 Jun; 44(6):1595-600. PubMed ID: 23632975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis: a cross-cultural validation in Caucasian and Han Chinese cohort.
    Liu J; Chen X; Guo X; Xu R; Wang Y; Liu M
    Ther Adv Neurol Disord; 2022; 15():17562864221129380. PubMed ID: 36225969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry.
    Shen Z; Jin H; Lu Y; Sun W; Liu R; Li F; Shu J; Tai L; Li G; Chen H; Zhang G; Zhang L; Sun X; Qiu J; Wei Y; Sun W; Huang Y
    Front Neurol; 2021; 12():727304. PubMed ID: 34650508
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score.
    Al-Khaled M; Langner B; Brüning T
    Acta Neurol Scand; 2016 Apr; 133(4):239-44. PubMed ID: 26033162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.